4 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Service d'aide à la décision clinique

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal Français d'Ophtalmologie
Volume 41, n° 10
pages e451-e467 (décembre 2018)
Doi : 10.1016/j.jfo.2018.10.002
Received : 12 September 2018 ;  accepted : 11 October 2018
Editor's choice


S. Salah a, , S. Abad b, D. Monnet a, A.P. Brézin a
a Department of Ophthalmology, hôpital Cochin, Assistance publique–Hôpitaux de Paris, université Paris Descartes, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France 
b Department of Internal Medicine, hôpital Avicenne, Assistance publique–Hôpitaux de Paris, 125, rue de Stalingrad, 93000 Bobigny, Paris, France 

Corresponding author.

Sarcoidosis is a systemic granulomatosis characterized by the formation of epithelioid and giant cell granulomas without caseous necrosis. To make the diagnosis, it is necessary to prove systemic granulomatosis involving at least two organs; but in practice, a combination of clinical, paraclinical and histologic findings is used. It affects predominantly women with a bimodal age distribution: 25–29 years and 65–69 years. The most commonly affected organs are the mediastinal lymphatic system, lungs, skin and eyes. Ophthalmological involvement is present in 20 to 50% of cases. The typical ocular presentation is that of granulomatous uveitis associated with venous retinal vasculitis and lesions of peripheral multifocal choroiditis. This ophthalmological presentation, although very evocative, is not always associated with systemic disease. The diagnosis of ocular sarcoidosis is then presumed in the absence of histological evidence. Algorithms combining ophthalmological and systemic signs have been proposed in cases of isolated uveitis. They make it possible to establish the diagnosis of ocular sarcoidosis with various levels of probability. The absence of significant granulomas on a systemic level during primary ocular involvement remains the main hypothesis to explain these diagnostic difficulties. Treatment is well described, as the uveitis of sarcoidosis is most often steroid responsive. In the case of corticosteroid-dependent uveitis, the first-line immunosuppressant remains methotrexate. The use of anti-tumor necrosis factor alpha is an interesting alternative in patients whose ocular sarcoidosis is refractory to conventional immunosuppressants.

The full text of this article is available in PDF format.

Keywords : Systemic granulomatosis, Epithelioid and giant cell granuloma, Granulomatous uveitis, Posterior uveitis, Multifocal choroiditis, Heerfordt syndrome, Mikulicz syndrome

 See this article, unabridged, illustrated and detailed, with electronic enhancements, in EMC – Ophtalmologie : Abad S, Salah S, Brezin A, Monnet D. Sarcoïdose. EMC – Ophtalmologie 2018;15(3):1-17 [Article 21-225-D-30].

© 2018  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline